• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Late effects in survivors of infant acute lymphoblastic leukaemia-a study of the Australian and New Zealand Children's Haematology/Oncology Group.

作者信息

Mironova Denitza, Saraswati Chitra M, Downie Peter, Lai Chow Yee, Cook Eleanor, Carruthers Vickyanne, Moukhaiber Perla, Molloy Fiona, Serov Joshua, McKinnon Elizabeth, Alvaro Frank, Osborn Michael, Revesz Tamas, Prestidge Tim, Cross Siobhan, Bateman Caroline M, Moore Andrew S, Khaw Seong Lin, Mateos Marion K, Kotecha Rishi S

机构信息

Department of Clinical Haematology, Oncology, Blood and Marrow Transplantation, Perth Children's Hospital, Perth, Australia.

Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Australia.

出版信息

Blood Cancer J. 2023 Sep 26;13(1):150. doi: 10.1038/s41408-023-00924-5.

DOI:10.1038/s41408-023-00924-5
PMID:37752126
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10522653/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/211e/10522653/4d120172cffe/41408_2023_924_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/211e/10522653/4d120172cffe/41408_2023_924_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/211e/10522653/4d120172cffe/41408_2023_924_Fig1_HTML.jpg

相似文献

1
Late effects in survivors of infant acute lymphoblastic leukaemia-a study of the Australian and New Zealand Children's Haematology/Oncology Group.婴儿急性淋巴细胞白血病幸存者的远期效应——澳大利亚和新西兰儿童血液学/肿瘤学组的一项研究
Blood Cancer J. 2023 Sep 26;13(1):150. doi: 10.1038/s41408-023-00924-5.
2
Haemopoietic stem cell transplantation for children in Australia and New Zealand, 1998-2006: a report on behalf of the Australasian Bone Marrow Transplant Recipient Registry and the Australian and New Zealand Children's Haematology Oncology Group.1998 - 2006年澳大利亚和新西兰儿童造血干细胞移植：代表澳大拉西亚骨髓移植受者登记处以及澳大利亚和新西兰儿童血液学肿瘤学组的报告
Med J Aust. 2009 Feb 2;190(3):121-5. doi: 10.5694/j.1326-5377.2009.tb02309.x.
3
Are outcomes for childhood leukaemia in Australia influenced by geographical remoteness and Indigenous race?澳大利亚儿童白血病的治疗结果是否受地理位置偏远和土著种族的影响？
Pediatr Blood Cancer. 2021 Apr;68(4):e28945. doi: 10.1002/pbc.28945. Epub 2021 Feb 9.
4
Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group.利用自动化电子健康记录提取技术确定的儿科白血病课程中的实验室不良事件发生率：来自儿童肿瘤学组的回顾性队列研究。
Lancet Haematol. 2022 Sep;9(9):e678-e688. doi: 10.1016/S2352-3026(22)00168-5. Epub 2022 Jul 20.
5
Treatment-related mortality in children with acute lymphoblastic leukaemia in a low-middle income country.中低收入国家儿童急性淋巴细胞白血病治疗相关死亡率。
J Pak Med Assoc. 2021 Oct;71(10):2373-2377. doi: 10.47391/JPMA.796.
6
Vitamin and mineral supplements in pregnancy and the risk of childhood acute lymphoblastic leukaemia: a case-control study.孕期维生素和矿物质补充剂与儿童急性淋巴细胞白血病风险：一项病例对照研究
BMC Public Health. 2007 Jul 3;7:136. doi: 10.1186/1471-2458-7-136.
7
[The treatment of leukaemia in paediatric haematology day hospital].
Soins Pediatr Pueric. 2015 Jul-Aug(285):17-21. doi: 10.1016/j.spp.2015.05.003.
8
Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.新诊断为标准风险急性淋巴细胞白血病的儿童治疗后晚期效应的风险：来自儿童癌症幸存者研究队列的报告。
Lancet Oncol. 2014 Jul;15(8):841-51. doi: 10.1016/S1470-2045(14)70265-7. Epub 2014 Jun 19.
9
The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study.儿童急性淋巴细胞白血病幸存者长期健康结局负担的变化：圣犹大终身队列研究的回顾性分析
Lancet Haematol. 2019 Jun;6(6):e306-e316. doi: 10.1016/S2352-3026(19)30050-X. Epub 2019 May 8.
10
Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.化疗治疗儿童急性淋巴细胞白血病幸存者的白质脑病及长期神经行为、神经认知和脑成像结果：一项纵向分析。
Lancet Haematol. 2016 Oct;3(10):e456-e466. doi: 10.1016/S2352-3026(16)30110-7. Epub 2016 Sep 14.

引用本文的文献

1
-rearranged acute lymphoblastic leukemia in infants: current progress and challenges.婴儿重排型急性淋巴细胞白血病：当前进展与挑战
Haematologica. 2025 Sep 1;110(9):1951-1961. doi: 10.3324/haematol.2024.285642. Epub 2025 Apr 10.
2
Preclinical Assessment of Dactinomycin in -Rearranged Infant Acute Lymphoblastic Leukemia.放线菌素D在重排型婴儿急性淋巴细胞白血病中的临床前评估
Cancers (Basel). 2025 Feb 5;17(3):527. doi: 10.3390/cancers17030527.

本文引用的文献

1
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia.Blinatumomab 联合化疗治疗婴儿急性淋巴细胞白血病。
N Engl J Med. 2023 Apr 27;388(17):1572-1581. doi: 10.1056/NEJMoa2214171.
2
Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer.右雷佐生对儿童癌症幸存者长期心脏功能的影响。
J Clin Oncol. 2023 Apr 20;41(12):2248-2257. doi: 10.1200/JCO.22.02423. Epub 2023 Jan 20.
3
Updates in infant acute lymphoblastic leukemia and the potential for targeted therapy.婴儿急性淋巴细胞白血病的最新进展和靶向治疗的潜力。
Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):611-617. doi: 10.1182/hematology.2022000359.
4
Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study.《国际多中心 III 期随机研究：婴儿急性淋巴细胞白血病采用 Interfant-06 方案治疗的结局》
J Clin Oncol. 2019 Sep 1;37(25):2246-2256. doi: 10.1200/JCO.19.00261. Epub 2019 Jul 8.
5
Late effects in survivors of infantile acute leukemia: a study of the L.E.A program.婴儿急性白血病幸存者的远期效应：L.E.A项目研究
Blood Cancer J. 2017 Jan 20;7(1):e518. doi: 10.1038/bcj.2016.129.
6
The evolution of clinical trials for infant acute lymphoblastic leukemia.婴儿急性淋巴细胞白血病临床试验的演变。
Blood Cancer J. 2014 Apr 11;4(4):e200. doi: 10.1038/bcj.2014.17.
7
Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group.基于风险的治疗对伴有或不伴有MLL基因重排的婴儿急性淋巴细胞白血病的疗效，重点关注远期效应：日本婴儿白血病研究组两项连续研究（MLL96和MLL98）的最终报告
Leukemia. 2007 Nov;21(11):2258-63. doi: 10.1038/sj.leu.2404903. Epub 2007 Aug 9.
8
Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia.急性淋巴细胞白血病婴儿的异基因造血细胞移植
Blood. 2005 May 1;105(9):3749-56. doi: 10.1182/blood-2004-08-3312. Epub 2005 Jan 6.
9
Late effects in survivors of infant leukemia.
Leukemia. 2000 Jul;14(7):1185-90. doi: 10.1038/sj.leu.2401818.
10
Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.急性淋巴细胞白血病患儿的神经发育结局：儿童癌症研究组报告
Cancer. 1999 Apr 15;85(8):1859-65. doi: 10.1002/(sici)1097-0142(19990415)85:8<1859::aid-cncr28>3.0.co;2-2.